566 related articles for article (PubMed ID: 23407630)
1. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK
Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction.
Clementy N; Pierre B; Lallemand B; Marie O; Lemoine E; Cosnay P; Fauchier L; Babuty D
Europace; 2012 Jul; 14(7):968-74. PubMed ID: 22389416
[TBL] [Abstract][Full Text] [Related]
3. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
4. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score.
van Rees JB; Borleffs CJ; van Welsenes GH; van der Velde ET; Bax JJ; van Erven L; Putter H; van der Bom JG; Schalij MJ
Heart; 2012 Jun; 98(11):872-7. PubMed ID: 22581736
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.
Magnusson P; Gadler F; Liv P; Mörner S
J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1088-94. PubMed ID: 26178879
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of pre-implantation hyponatremia on morbidity and mortality among patients with left ventricular dysfunction and implantable cardioverter-defibrillators.
Bhavnani SP; Kumar A; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
Europace; 2014 Jan; 16(1):47-54. PubMed ID: 23954920
[TBL] [Abstract][Full Text] [Related]
8. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.
Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH
J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337
[TBL] [Abstract][Full Text] [Related]
10. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.
Sood N; Ruwald AC; Solomon S; Daubert JP; McNitt S; Polonsky B; Jons C; Clyne CA; Zareba W; Moss AJ
Eur Heart J; 2014 Jan; 35(2):106-15. PubMed ID: 24179073
[TBL] [Abstract][Full Text] [Related]
11. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
[TBL] [Abstract][Full Text] [Related]
12. A comparison of outcomes for patients receiving implantable cardioverter defibrillators for primary vs secondary-prevention.
Giedrimas A; Giedrimiene D; Guertin D; White CM; Clyne CA; Kluger J
Conn Med; 2008; 72(6):329-33. PubMed ID: 18610705
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.
Smit MD; Van Dessel PF; Rienstra M; Nieuwland W; Wiesfeld AC; Tan ES; Anthonio RL; Van Veldhuisen DJ; Van Gelder IC
Europace; 2006 Aug; 8(8):566-72. PubMed ID: 16864611
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention.
Friedman PA; Bradley D; Koestler C; Slusser J; Hodge D; Bailey K; Kusumoto F; Munger TM; Militanu A; Glikson M
Europace; 2014 Oct; 16(10):1460-8. PubMed ID: 24928948
[TBL] [Abstract][Full Text] [Related]
19. Risk of ventricular tachyarrhythmias following improvement of left ventricular ejection fraction in patients with implantable cardiac defibrillators implanted for primary prevention of sudden cardiac death.
Pillarisetti J; Gopinathannair R; Haney MJ; Abazid B; Rawasia W; Reddy MY; Adabala N; Bommana S; Emert M; Lakkireddy D
J Interv Card Electrophysiol; 2017 Apr; 48(3):283-289. PubMed ID: 28150095
[TBL] [Abstract][Full Text] [Related]
20. Association of Implantable Cardioverter Defibrillator Therapy with All-Cause Mortality-A Systematic Review and Meta-Analysis.
Qian Z; Zhang Z; Guo J; Wang Y; Hou X; Feng G; Zou J
Pacing Clin Electrophysiol; 2016 Jan; 39(1):81-8. PubMed ID: 26470761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
